MedTrace Logo

Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

NCT01768403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1236

Last updated 2013-01-15

No results posted yet for this study

Summary

Centralized Pan-Algerian Survey on the undertreatment of hypercholesterolemia. The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines in the survey population.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Habib BENNACEUR, MD · AstraZeneca

  • Nawel BOUTEKDJIRET, MD · AstraZeneca

  • Yassin BOUHOUITA-GUERMECH, Professor · Cardiology department /Mustapha Bacha Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-03-31
Completion
2011-03-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768403 on ClinicalTrials.gov